SCHEMBL44430

SCHEMBL44430

NC(=O)C=Cc1cc(F)cc(C(F)(F)F)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.46
CYP1A2 P05177 1/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
RPS6KA3 P51812 1/20 0.42
JAK3 P52333 1/20 0.42
MAOB P27338 3/20 0.41
BACE1 P56817 1/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
PKM P14618 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
HDAC3 O15379 1/20 0.39
ADAM17 P78536 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL44429 1.00 KDR (0.46) KDRCYP1A2CYP1A1CYP1B1RPS6KA3
SCHEMBL6031030 0.90 RPS6KA3 (0.50) KDRCYP1A2CYP1A1CYP1B1RPS6KA3
SCHEMBL3898497 0.90 RPS6KA3 (0.50) KDRCYP1A2CYP1A1CYP1B1RPS6KA3
SCHEMBL3930279 0.85 CYP1A2 (0.43) CYP1A2CYP1A1CYP1B1MAOBBACE1
SCHEMBL3930273 0.85 CYP1A2 (0.43) CYP1A2CYP1A1CYP1B1MAOBBACE1
SCHEMBL8148781 0.84 BACE1 (0.51) KDRBACE1HTTHDAC3HDAC1
SCHEMBL8148789 0.84 BACE1 (0.51) KDRBACE1HTTHDAC3HDAC1
SCHEMBL20568577 0.83 KDR (0.43) KDRCYP1A2CYP1A1CYP1B1RPS6KA3
SCHEMBL6821841 0.83 CYP1A2 (0.42) CYP1A2CYP1A1CYP1B1MAOBBACE1
Hydrochloric Acid SCHEMBL6821843 0.83 CYP1A2 (0.42) CYP1A2CYP1A1CYP1B1MAOBBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110313196-A1 NOVEL PROCESS HOFFMANN-LA ROCHE, INC. 2011-12-22 US disclosed
WO-2011157670-A2 NOVEL PROCESS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110313196-A1 NOVEL PROCESS CYP3A5, CYP3A4, GBA1 KDR 3772/4885CYP1A2 119/4885CYP1A1 532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.